ORI
SGMO

Oak Ridge Investments’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Oak Ridge Investments’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-10,506
Closed -$165K – 149
2015
Q1 		$165K Sell
10,506
-5,776
-35% -$89.4K ﹤0.01% 147
2014
Q4 		$248K Sell
16,282
-1,603
-9% -$19.5K 0.01% 140
2014
Q3 		$193K Hold
17,885
– – 0.01% 142
2014
Q2 		$273K Buy
17,885
+888
+5% +$12.8K 0.01% 132
2014
Q1 		$307K Buy
16,997
+6,722
+65% +$130K 0.01% 133
2013
Q4 		$143K Buy
+10,275
New +$118K ﹤0.01% 133

Other funds holding SGMO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Oak Ridge Investments's SGMO Position: Q2 2015 in Review

Oak Ridge Investments sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2015, closing a stake of 10,506 shares — an estimated $165K sold.

Oak Ridge Investments first reported a position in SGMO in Q4 2013 and held it in 6 quarters. The position peaked at $307K in Q1 2014. 156 funds tracked by Wall St. Rank hold SGMO as of Q2 2015.

  • Oak Ridge Investments reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2015 after selling out during the quarter.
  • Oak Ridge Investments sold 10,506 SANGAMO THERAPEUTICS INC shares in Q2 2015, an estimated $165K.
  • Oak Ridge Investments first reported a position in SANGAMO THERAPEUTICS INC in Q4 2013 and held it in 6 quarters.
  • Oak Ridge Investments's SANGAMO THERAPEUTICS INC position peaked at $307K in Q1 2014.
  • 156 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2015.

Based on Oak Ridge Investments's 13F filing for Q2 2015, filed 4 Aug 2015.